As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

The five supplement groups in Washington all have very different — and very strong — feelings about the main bill being considered.

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

It’s UFA week in Washington

Read the rest…